Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses
K-Number: K161100 · 2016-08-10
Device Summary
Frequently Asked Questions
What is the Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses?
Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses is a medical device that received FDA 510(k) clearance on 2016-08-10. It is manufactured by Contamac, Ltd.. The 510(k) number is K161100.
When was Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses approved by the FDA?
Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses received FDA 510(k) clearance on 2016-08-10, under approval number K161100.
What company makes Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses?
Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses is manufactured by Contamac, Ltd..
What is the FDA product code for Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses?
The FDA product code for Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses is HQD.
Related Clinical Trials
Other Devices by Contamac, Ltd.
Related Devices (Code: HQD)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.